drugset
drugset / Trial / NCT01926769

A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

NCT01926769 ↗

Phase 2 Terminated 2 enrolled Gachon University Gil Medical Center
NaSingle-groupOpen-labelTreatment

Summary

To determine the safety and efficacy of second-line treatment with Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the second line treatment of advanced colorectal cancer

Timeline

Start
2012-02
Primary completion
2014-12
Completion
2014-12

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual rate”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — —

Indications

No indication recorded.